A detailed history of Cboe Vest Financial, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cboe Vest Financial, LLC holds 20,491 shares of GILD stock, worth $2.54 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
20,491
Previous 14,472 41.59%
Holding current value
$2.54 Million
Previous $1.6 Million 41.77%
% of portfolio
0.03%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 29, 2025

BUY
$108.22 - $120.47 $651,376 - $725,108
6,019 Added 41.59%
20,491 $2.27 Million
Q2 2025

Jul 25, 2025

BUY
$96.91 - $113.0 $395,392 - $461,040
4,080 Added 39.26%
14,472 $1.6 Million
Q1 2025

Apr 10, 2025

BUY
$89.14 - $117.41 $392,483 - $516,956
4,403 Added 73.52%
10,392 $1.16 Million
Q4 2024

Jan 28, 2025

BUY
$83.95 - $97.9 $63,969 - $74,599
762 Added 14.58%
5,989 $553,000
Q3 2024

Oct 18, 2024

BUY
$66.59 - $83.99 $348,065 - $439,015
5,227 New
5,227 $438,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $156B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cboe Vest Financial, LLC Portfolio

Follow Cboe Vest Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cboe Vest Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cboe Vest Financial, LLC with notifications on news.